NYSE: CALCaleres Inc Stock
$15.20-0.40 (-2.56%)
Updated Sep 16, 2025
CAL Price
$15.20
Fair Value Price
N/A
Market Cap
$514.41M
52 Week Low
$12.09
52 Week High
$34.53
P/E
8.54x
P/B
0.84x
P/S
0.17x
PEG
0.4x
Dividend Yield
1.84%
Revenue
$2.65B
Earnings
$60.01M
Gross Margin
44%
Operating Margin
3.25%
Profit Margin
2.3%
Debt to Equity
2.5
Operating Cash Flow
$31M
Beta
1.36
Next Earnings
N/A
Ex-Dividend
Sep 12, 2025
Next Dividend
Sep 26, 2025
CAL Overview
Caleres Inc. is a footwear company offering its products under the Naturalizer, Dr. Scholl's, LifeStride, Ryka, and Franco Sarto brands. Its 1,200 retail shoe stores in the U.S., Canada, and Italy are branded as Famous Footwear, LifeStride, Naturalizer, Blowfish Malibu, Fergie Footwear, and Allen Edmonds. Caleres was founded in 1878 and is headquartered in St. Louis, MO.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CAL's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Apparel
Industry Rating
C
CAL
Ranked#18 of 28
Ranked#18 of 28
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $70.33 | A | |
| $60.81 | B | |
| $15.30 | B |
Be the first to know about important CAL news, forecast changes, insider trades & much more!
CAL News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CAL scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CAL ($15.20) is trading below its intrinsic value of $25.18, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CAL is good value based on its earnings relative to its share price (8.54x), compared to the US market average (37.55x)
P/E vs Market Valuation
CAL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CAL due diligence checks available for Premium users.
Valuation
CAL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
8.54x
Industry
25.01x
Market
37.55x
CAL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CAL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CAL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.84x
Industry
7.73x
CAL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CAL price to earnings growth (PEG)
For valuing profitable companies with growth potential
CAL is good value based... subscribe to Premium to read more.
PEG Value Valuation
CAL's financial health
Profit margin
Revenue
$658.5M
Net Income
$6.7M
Profit Margin
1%
CAL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CAL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.2B
Liabilities
$1.5B
Debt to equity
2.5
CAL's short-term assets ($1.10B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CAL's short-term assets ($1.10B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CAL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CAL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$47.3M
Investing
-$12.9M
Financing
$123.9M
CAL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CAL vs Apparel Stocks
Caleres Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.